Vaxxinity (VAXX) Insider Trading & Ownership $0.0002 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Vaxxinity (NASDAQ:VAXX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage64.06%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$365,119.53Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$2.71 M Get VAXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxxinity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VAXX Insider Buying and Selling by Quarter Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Vaxxinity Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/20/2023Rick ScottU.S. Congress Member (R-FL)Sell$0.70$1,001 - $15,0009/8/2023Movers Lab Fund I Lp PrimeMajor ShareholderSell25,089$1.67$41,898.63 9/6/2023Movers Lab Fund I Lp PrimeMajor ShareholderSell5,308$1.88$9,979.04 1/23/2023Movers Lab Fund I Lp PrimeMajor ShareholderSell405,217$3.35$1,357,476.95 12/1/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell270,964$2.97$804,763.08 9/6/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell25,243$2.40$60,583.20 8/25/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell22,757$2.33$53,023.81 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/23/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell33,785$2.45$82,773.25 6/16/2022Lou ReeseChairmanBuy100,000$1.99$199,000.00 6/13/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell92,569$2.43$224,942.67 6/10/2022Movers Lab Fund I Lp PrimeMajor ShareholderSell28,378$2.80$79,458.40 6/9/2022Mei Mei HuInsiderBuy10,978$2.72$29,860.16 6/8/2022United Biomedical IncMajor ShareholderBuy10,000$2.95$29,500.00 4/27/2022Lou ReeseChairmanBuy4,807$3.58$17,209.06 4/26/2022United Biomedical IncMajor ShareholderBuy18,105$3.45$62,462.25 4/25/2022Mei Mei HuInsiderBuy8,038$3.37$27,088.06 (Data available from 1/1/2013 forward) VAXX Insider Trading Activity - Frequently Asked Questions Who is on Vaxxinity's Insider Roster? The list of insiders at Vaxxinity includes Lou Reese, Mei Mei Hu, Movers Lab Fund I Lp Prime, and United Biomedical Inc. Learn more on insiders at VAXX. What percentage of Vaxxinity stock is owned by insiders? 64.06% of Vaxxinity stock is owned by insiders. Learn more on VAXX's insider holdings. Which Vaxxinity insiders have been selling company stock? The following insider sold VAXX shares in the last 24 months: Movers Lab Fund I Lp Prime ($2,214,117.70). How much insider selling is happening at Vaxxinity? Insiders have sold a total of 706,578 Vaxxinity shares in the last 24 months for a total of $2,214,117.70 sold. Which members of congress are trading Vaxxinity? Rick Scott (R-FL) has sold shares of Vaxxinity in the last year totaling $8,000. Vaxxinity Key ExecutivesMr. Louis Garfield Reese IV (Age 42)Co-Founder & Executive Chairman of the Board Compensation: $275.57kMs. Mei Mei Hu J.D. (Age 41)Co-Founder, President, CEO & Director Compensation: $345.14kMs. Sumita Ray J.D. (Age 50)Chief Legal, Compliance & Administrative Officer and Corporate Secretary Compensation: $465.56kDr. Jean-Cosme Dodart Ph.D.Chief Scientific OfficerMr. Jon HarrisonChief Government OfficerMr. Mark Joinnides MSEChief of StaffMs. Amy B. Fix M.B.A.M.S., R.A.C., Head of Regulatory More Insider Trading Tools from MarketBeat Related Companies Calithera Biosciences Insider Buying Evelo Biosciences Insider Buying Ampio Pharmaceuticals Insider Buying Comera Life Sciences Insider Buying Genocea Biosciences Insider Buying eFFECTOR Therapeutics Insider Buying biote Insider Buying Clever Leaves Insider Buying Fortress Biotech Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:VAXX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxxinity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VAXX Stock Alerts